NeoGenomics Inc. | Mutual Funds
Mutual Funds that own NeoGenomics Inc.
Janus Venture Fund
2,728,660
2.98%
0
1.02%
06/30/2018
Vanguard Total Stock Market Index Fund
1,764,567
1.93%
0
0%
07/31/2018
Franklin Small Cap Growth Fund
1,362,000
1.49%
650,200
0.63%
03/31/2018
Artisan Small Cap Fund
1,341,995
1.47%
46,821
1.02%
06/30/2018
Janus Global Life Sciences Fund
1,336,780
1.46%
-44,342
0.45%
06/30/2018
iShares Russell 2000 ETF
1,178,540
1.29%
-630
0.03%
09/06/2018
Russell US Small Cap Equity Fund
1,089,684
1.19%
20,818
0.69%
04/30/2018
Vanguard Extended Market Index Fund
773,566
0.85%
0
0.02%
07/31/2018
Janus Capital Funds Plc - Global Life Sciences Fund
742,881
0.81%
742,881
0.4%
12/31/2017
Federated Kaufmann Small Cap Fund
618,900
0.68%
71,600
0.53%
06/29/2018
| Address |
12701 Commonwealth Drive
Fort Myers Florida 33913
United States
|
|
Employees
|
- |
| Website |
http://www.neogenomics.com |
| Updated |
07/08/2019 |
| NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. |
